

share
Biciromab CAS NO 138783-13-8
Unit Price:
CAS No.:138783-13-8
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Biciromab CAS NO 138783-13-8 is a monoclonal antibody with specific binding affinity. This compound is a critical reagent in advanced biomedical research and diagnostic development. It is primarily utilized by pharmaceutical R&D teams and diagnostic manufacturers for targeted applications in immunology and oncology.
Application
- Research Reagent: Used as a primary or secondary antibody in immunological assays such as ELISA, Western Blot, and flow cytometry.
- Diagnostic Development: Serves as a key component in the development of in-vitro diagnostic (IVD) kits for specific antigen detection.
- Target Validation: Employed in preclinical research to validate and characterize specific cellular targets in disease models.
- Biomarker Discovery: Utilized in proteomics and histopathology to identify and study potential disease biomarkers.
- Therapeutic Antibody Research: Acts as a reference or comparator in the development and screening of novel therapeutic monoclonal antibodies.
- Cell Sorting and Isolation: Applied in conjunction with magnetic or fluorescent activated cell sorting (MACS/FACS) techniques for specific cell population isolation.
Basic Information
| Product Name | Biciromab |
| CAS No. | 138783-13-8 |
| Molecular Formula | Contact for details |
| Molecular Weight | Contact for details |
| Synonyms | Biciromab; Anti-Fibrin II beta chain antibody; Monoclonal antibody Biciromab; 138783-13-8; Biciromab (USAN); Anti-human fibrin monoclonal antibody; BICIROMAB (USAN); Biciromab [USAN] |
| EINECS | Contact for details |
Quality Control
Our Biciromab is produced and tested under stringent quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, potency, and stability. Certificates of Analysis (COA) documenting purity by HPLC, endotoxin levels, sterility, and binding activity are available upon request. We adhere to relevant guidelines for research-grade biological materials.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive); ensure the container is sealed properly after each use to prevent moisture uptake. Aliquot into working volumes upon receipt to maintain integrity.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear solution |
| Identification (HPLC/LC-MS) | Conforms to reference standard |
| Purity (SDS-PAGE) | > 95% |
| Protein Concentration | As per COA (typically 1 mg/mL) |
| Endotoxin Level | < 1.0 EU/mg |
| Binding Activity (ELISA) | Conforms to reference |
| Sterility (Membrane Filtration) | Sterile |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9


Pritumumab CAS NO 499212-74-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






